These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 15730988)
1. Daytime pulsed dose rate brachytherapy as a new treatment option for previously irradiated patients with recurrent oesophageal cancer. Harms W; Krempien R; Grehn C; Berns C; Hensley FW; Debus J Br J Radiol; 2005 Mar; 78(927):236-41. PubMed ID: 15730988 [TBL] [Abstract][Full Text] [Related]
2. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer. Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017 [TBL] [Abstract][Full Text] [Related]
3. Palliation of dysphagia in advanced, metastatic or recurrent carcinoma oesophagus with high dose rate intraluminal brachytherapy--an eastern Indian experience of 35 cases. Ghosh S; Sau S; Mitra S; Manna A; Ghosh K J Indian Med Assoc; 2012 Jul; 110(7):449-52. PubMed ID: 23520668 [TBL] [Abstract][Full Text] [Related]
4. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer. Harms W; Krempien R; Hensley FW; Berns C; Fritz P; Wannenmacher M Strahlenther Onkol; 2002 Nov; 178(11):607-14. PubMed ID: 12426671 [TBL] [Abstract][Full Text] [Related]
5. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept. Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784 [TBL] [Abstract][Full Text] [Related]
6. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center. Bhatt L; Tirmazy S; Sothi S Dis Esophagus; 2013 Jan; 26(1):57-60. PubMed ID: 22404484 [TBL] [Abstract][Full Text] [Related]
7. Treatment of recurrent bronchial carcinoma: the role of high-dose-rate endoluminal brachytherapy. Hauswald H; Stoiber E; Rochet N; Lindel K; Grehn C; Becker HD; Debus J; Harms W Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):373-7. PubMed ID: 19836162 [TBL] [Abstract][Full Text] [Related]
8. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer. Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851 [TBL] [Abstract][Full Text] [Related]
9. Locally recurrent breast cancer: pulse dose rate brachytherapy for repeat irradiation following lumpectomy-- a second chance to preserve the breast. Resch A; Fellner C; Mock U; Handl-Zeller L; Biber E; Seitz W; Pötter R Radiology; 2002 Dec; 225(3):713-8. PubMed ID: 12461250 [TBL] [Abstract][Full Text] [Related]
10. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
11. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer. Strnad V; Geiger M; Lotter M; Sauer R Brachytherapy; 2003; 2(3):158-63. PubMed ID: 15062138 [TBL] [Abstract][Full Text] [Related]
12. Results of chest wall reirradiation using pulsed-dose-rate (PDR) brachytherapy molds for breast cancer local recurrences. Harms W; Krempien R; Hensley FW; Berns C; Wannenmacher M; Fritz P Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):205-10. PubMed ID: 11163516 [TBL] [Abstract][Full Text] [Related]
13. Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer. Homs MY; Steyerberg EW; Eijkenboom WM; Siersema PD; Brachytherapy; 2006; 5(1):41-8. PubMed ID: 16563996 [TBL] [Abstract][Full Text] [Related]
14. Partial breast re-irradiation for local recurrence of breast carcinoma: Benefit and long term side effects. Sedlmayer F; Zehentmayr F; Fastner G Breast; 2013 Aug; 22 Suppl 2():S141-6. PubMed ID: 24074775 [TBL] [Abstract][Full Text] [Related]
15. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients. Chargari C; Magné N; Dumas I; Messai T; Vicenzi L; Gillion N; Morice P; Haie-Meder C Int J Radiat Oncol Biol Phys; 2009 May; 74(1):133-9. PubMed ID: 18774656 [TBL] [Abstract][Full Text] [Related]
16. Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer. Hirdes MM; van Hooft JE; Wijrdeman HK; Hulshof MC; Fockens P; Reerink O; van Oijen MG; van der Tweel I; Vleggaar FP; Siersema PD Gastrointest Endosc; 2012 Aug; 76(2):267-74. PubMed ID: 22695208 [TBL] [Abstract][Full Text] [Related]
17. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495 [TBL] [Abstract][Full Text] [Related]
18. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Homs MY; Steyerberg EW; Eijkenboom WM; Tilanus HW; Stalpers LJ; Bartelsman JF; van Lanschot JJ; Wijrdeman HK; Mulder CJ; Reinders JG; Boot H; Aleman BM; Kuipers EJ; Siersema PD Lancet; 2004 Oct 23-29; 364(9444):1497-504. PubMed ID: 15500894 [TBL] [Abstract][Full Text] [Related]
19. Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina. Nag S; Martínez-Monge R; Copeland LJ; Vacarello L; Lewandowski GS Gynecol Oncol; 1997 Jul; 66(1):16-9. PubMed ID: 9234914 [TBL] [Abstract][Full Text] [Related]
20. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Sur RK; Donde B; Levin VC; Mannell A Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):447-53. PubMed ID: 9457834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]